BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAB8. A total of 39 filers reported holding BRIDGEBIO PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,400,000 | -44.6% | 2,500,000 | -54.5% | 0.01% | -47.6% |
| Q2 2023 | $4,332,448 | +6.3% | 5,500,000 | 0.0% | 0.02% | 0.0% |
| Q1 2023 | $4,075,500 | +6.5% | 5,500,000 | -35.3% | 0.02% | -25.0% |
| Q4 2022 | $3,825,000 | -24.9% | 8,500,000 | 0.0% | 0.03% | -9.7% |
| Q3 2022 | $5,090,000 | -12.5% | 8,500,000 | -19.0% | 0.03% | +10.7% |
| Q2 2022 | $5,815,000 | -13.4% | 10,500,000 | -8.7% | 0.03% | +55.6% |
| Q1 2022 | $6,716,000 | -32.5% | 11,500,000 | -14.8% | 0.02% | +5.9% |
| Q4 2021 | $9,952,000 | -28.0% | 13,500,000 | +35.0% | 0.02% | -37.0% |
| Q3 2021 | $13,822,000 | -24.0% | 10,000,000 | -9.1% | 0.03% | -50.0% |
| Q1 2021 | $18,198,000 | – | 11,000,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 17,000,000 | $16,407,550 | 4.62% |
| BRAIDWELL LP | 114,338,000 | $109,764,480 | 3.47% |
| Castle Creek Arbitrage, LLC | 10,000,000 | $9,635,000 | 2.27% |
| ARISTEIA CAPITAL, L.L.C. | 67,223,000 | $64,534,080 | 1.74% |
| Graham Capital Management, L.P. | 55,529,000 | $53,481,723 | 1.26% |
| 683 Capital Management, LLC | 14,750,000 | $14,186,550 | 1.10% |
| TFG Asset Management GP Ltd | 5,850,000 | $5,622,500 | 1.02% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 21,875,000 | $21,039,375 | 0.87% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 33,421,000 | $32,084,160 | 0.75% |
| Context Capital Management, LLC | 6,110 | $5,858 | 0.47% |